Selecting analytical biomarkers for diagnostic applications: a first principles approach.

Area of Science:

• Biomarker discovery and development
• Clinical diagnostics
• Medical technology assessment

Background:

• Biomarkers are measurable indicators of medical state, crucial for disease diagnosis and monitoring physiological changes.
• Traditional biomarkers rely on detecting disease-specific molecules or physiological signatures.
• Existing methods require a systematic approach for selecting optimal biomarkers across diverse healthcare settings.

Purpose of the Study:

• To provide a framework for selecting biomarkers that offer the most valuable information about a patient's disease state.
• To guide the development of diagnostic tests by analyzing trade-offs between biomarker properties and detection complexity.
• To ensure biomarker utility in various healthcare settings, including resource-limited environments.

Main Methods:

• Developing a framework for biomarker selection based on clinical utility and analytical detectability.
• Analyzing the trade-offs between biomarker sensitivity, specificity, and detection complexity.
• Evaluating additional criteria for successful diagnostic test development.

Main Results:

• Biomarker selection should prioritize answering explicit clinical questions, particularly those concerning a causative relationship with the disease state.
• The framework facilitates understanding the balance between a biomarker's diagnostic power and the practicality of its detection.
• Consideration of detection complexity is vital for applying biomarkers across different healthcare resource levels.

Conclusions:

• A structured approach to biomarker selection, driven by clinical needs, enhances the development of effective diagnostic tools.
• The proposed framework aids test developers and clinicians in navigating the complexities of biomarker assessment.
• This strategy supports the identification and implementation of valuable biomarkers in diverse healthcare contexts.